Jessica Wagoner

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants”.

Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants

Journal of Ethnopharmacology(2021)10.1016/j.jep.2021.114016

N/A

0DataRank · unranked

126 citations

Yiming Huang, David A. Fidock, Stephen J. Polyak, Jessica Wagoner, Melissa J. Towler +2 more

Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01146-20

N/A

0DataRank · unranked

42 citations

Jessica M. Oda, Jessica Wagoner, Delaney Kirchmeier, Aidan O’Connor, Elizabeth A. Nelson +13 more

Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2

Microbiology Spectrum(2022)10.1128/spectrum.03331-22

N/A

0DataRank · unranked

67 citations

Shawn Herring, Tien-Ying Hsiang, Aleksandr Ianevski, Scott B. Biering, Shuang Xu +8 more

Modulation of in Vitro SARS-CoV-2 Infection by Stephania tetrandra and Its Alkaloid Constituents

Journal of Natural Products(2023)10.1021/acs.jnatprod.3c00159

N/A

0DataRank · unranked

11 citations

Zoie L. Bunch, Jessica Wagoner, Vandana Ravindran, Jessica M. Oda, Warren S. Vidar +12 more

A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound

medRxiv(2023)10.1101/2023.08.23.23294505

N/A

0DataRank · unranked

7 citations

Katherine Owens, Jessica Wagoner, Stephen J. Polyak, Judith M. White, Joshua T. Schiffer +1 more

A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy

Nature Communications(2024)10.1038/s41467-024-49458-9

N/A

0DataRank · unranked

29 citations

Katherine Owens, Jessica Wagoner, Stephen J. Polyak, Judith M. White, Joshua T. Schiffer +1 more